Complete Genomics | GenomeWeb

Complete Genomics

BGISEQ-50

The new BGISEQ-50, a smaller version of the BGISEQ-500, will have research and clinical applications, and BGI plans to register it with the CFDA, too.

The PGP team used Complete Genomics' Long-Fragment Read technology to analyze the set of samples.

Last year, Radboud University Medical Centre's genetics lab conducted about 6,000 diagnostic exome tests and ran 2,000 nex-gen sequencing-based BRCA1/2 hereditary cancer assays.

Genos Research, a Complete Genomics spinoff, plans to build a large database of individuals with sequenced exomes and genomes, allowing them to license their data to researchers. 

Mao Mao

Mao Mao joined BGI Genomics in February from WuXi AppTec, where he was responsible for in vitro diagnostics product development and clinical lab services.

Genome sequences for 600 disease-free individuals over 80 years old suggest protective variants related to cognition may mitigate disease and boost healthspan.

The study sequenced the genomes of 300 deceased patients and found many variants consistent with diseases and adverse drug events the patients encountered during their lives.

Pacific Biosciences' launch of the Sequel instrument, Oxford Nanopore Technologies' MinIon instrument, and 10X Genomics' technology excited the market in 2015.

Using genome, exome, and other data, researchers provide evidence for a Fanconi anemia subtype characterized by de novo, dominant negative mutations in RAD51.

The company plans to lay off 145 employees at its Mountain View headquarters, as well as 15 in San Jose, 13 in Sunnyvale, and six in San Francisco.

Pages

In PLOS this week: genetic study of breast cancer in Egyptian families, mutations linked to cleft lip and palate, and more.

Council Bluffs, Iowa, schools are encouraging more girls to pursue STEM courses, according to the Associated Press.

Because of new open-access requirements, Gates Foundation-funded researchers can't publish in some top journals, Nature News reports.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.